Impact of RSV Prevention in Infancy on Prevalence of Asthma Among 9–14-Year-old Native American Children in the Southwest United States
Asthma-related outcomes occurred less frequently among children who received motavizumab compared with placebo in infancy; however, these findings were not statistically significant, related to insufficient study power. The potential for reduction in asthma related to the prevention of RSV should be further evaluated in larger studies, especially given the elevated asthma prevalence observed in Native American children in this study.
Authors
- Rachel M. Hartman (ORCID: https://orcid.org/0000-0002-6837-4629)
- Kamellia Kellywood
- Laura B. Brown
- Ruth A. Karron (ORCID: https://orcid.org/0000-0002-4448-4946)
- Jessica E. Atwell (ORCID: https://orcid.org/0000-0003-1169-6456)
- Samantha Martin
- Katherine L. O'Flynn O'Brien (ORCID: https://orcid.org/0000-0002-0164-4030)
- Carol Tso
- Laura L. Hammitt (ORCID: https://orcid.org/0000-0001-6051-1484)
- Robert Weatherholtz (ORCID: https://orcid.org/0000-0003-4366-7473)
- Ladonna Becenti
Institutions
- Johns Hopkins University (US)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1097/inf.0000000000004818
- Citations
- 2
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 2.71